期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Impact of Long-Term Treatment with OROS Methylphenidate on Pubertal Development in Adolescents with ADHD 被引量:1
1
作者 Paul Hammerness daniel geller +6 位作者 Gagan Joshi Anna Georgiopoulos Robert Doyle Thomas Spencer Carter Petty Laura Mahoney Joseph Biederman 《Open Journal of Psychiatry》 2014年第2期147-152,共6页
The objective of this study was to examine whether stimulants impact pubertal development in adolescent Attention Deficit Hyperactivity Disorder (ADHD), an understudied subject. Pubertal staging data were collected du... The objective of this study was to examine whether stimulants impact pubertal development in adolescent Attention Deficit Hyperactivity Disorder (ADHD), an understudied subject. Pubertal staging data were collected during a 2-year open study of extended release methylphenidate in adolescents (N = 111) with ADHD. Tanner stages were compared to national estimates. The sample was primarily male, Caucasian, and a mean age of 14.8 years at baseline. The baseline Tanner stage for 70% of subjects was consistent with chronological age. For the majority of subjects who reached 12 - 20 months (N = 25) or 24 months (N = 21) endpoints, the Tanner stage at respective endpoints was consistent with age. We found that progression in Tanner stage was not associated with OROS MPH duration or dose (p > 0.10). Long-term treatment with extended release methylphenidate did not appear to adversely impact pubertal development in this sample of adolescents with ADHD. 展开更多
关键词 METHYLPHENIDATE Puberty DEVELOPMENT Adolescents ADHD
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部